{"filing":{"accession_number":"0001935979-26-000048","cik":"0001935979","ticker":"BHVN","company_name":"Biohaven Ltd.","form":"8-K","filing_date":"2026-05-27","report_date":null,"primary_document":"bhvn-20260526.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597926000048/bhvn-20260526.htm"},"events":[{"id":8895,"run_id":7807,"accession_number":"0001935979-26-000048","anchor_item_number":"7.01","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"summary":"Biohaven disclosed new clinical data in epilepsy with opakalim and positive clinical biomarker/patient data via press releases and an R\u0026D Day presentation on May 26-27, 2026. While clinical trial results can be material to investors evaluating pipeline progress and commercial prospects, this disclosure does not fit the standard taxonomy categories (not an earnings release, not a formal restatement, not an impairment). The material nature of clinical data warrants classification as other_material rather than a routine disclosure.","company_name":"Biohaven Ltd.","ticker":"BHVN","filing_date":"2026-05-27","form":"8-K","submitted_at":null,"items":[{"id":2115,"accession_number":"0001935979-26-000048","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"Biohaven disclosed new clinical data in epilepsy with opakalim and positive clinical biomarker/patient data via press releases and an R\u0026D Day presentation on May 26-27, 2026. While clinical trial results can be material to investors evaluating pipeline progress and commercial prospects, this disclosure does not fit the standard taxonomy categories (not an earnings release, not a formal restatement, not an impairment). The material nature of clinical data warrants classification as other_material rather than a routine disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:41:57.233831+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2115,"accession_number":"0001935979-26-000048","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"Biohaven disclosed new clinical data in epilepsy with opakalim and positive clinical biomarker/patient data via press releases and an R\u0026D Day presentation on May 26-27, 2026. While clinical trial results can be material to investors evaluating pipeline progress and commercial prospects, this disclosure does not fit the standard taxonomy categories (not an earnings release, not a formal restatement, not an impairment). The material nature of clinical data warrants classification as other_material rather than a routine disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:41:57.233831+00:00","company_name":"Biohaven Ltd.","ticker":"BHVN","filing_date":"2026-05-27"}]}